SAN FRANCISCO--(BUSINESS WIRE)--3Scan, (www.3scan.com), developer of transformative technologies for pathology and a revolutionary new Knife Edge Scanning Microscope (KESM) for powerful, rapid diagnostic and therapeutic discovery applications, announced today that it has closed a Series A fundraising round of $6.7 million. The financing, led by Lux Capital will support the continued development and deployment of 3Scan’s KESM technology. "While medical science has made incredible advances in rec
| < Prev | Next > |
|---|
_(1).jpg){kind=link}